US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,379.06

+4.600.33%

Number of Gainers:9

Number of Losers:9

Number of Flat:1

PE:- -

High:1,392.07

Open:1,378.91

Low:1,377.90

Close:1,374.47

Loading ...

J&J : Leerink Partners Raises Target Price to $171 From $153

THOMSON REUTERS

Ocugen to Host Conference Call on Friday, August 1 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2025 Financial Results

J&J : Bofa Global Research Raises Price Objective to $175 From $161

THOMSON REUTERS

IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine. -- Barrons.com

Barclays Remains a Hold on Johnson & Johnson (JNJ)

Is Johnson & Johnson a Good Dividend Stock to Buy Now?

Johnson & Johnson: Strong Performance Overshadowed by Biosimilar Competition and Litigation Risks

Johanna Mercier, Chief Commercial Officer, Reports Disposal of Gilead Sciences Inc. Common Shares

Gilead Sciences CFO Andrew D. Dickinson Reports Disposal of Common Shares

Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025

US STOCKS-Wall Street ends higher after brief slump on Powell firing confusion

J&J Sees Lower Tariff Risk for the Year -- Market Talk

Pfizer’s Latest Clinical Study: A New Hope for Advanced Melanoma Treatment?

Gilead Sciences Advances in Triple-Negative Breast Cancer Treatment

Pfizer’s BeneFIX Study Completion: Market Implications and Insights

J&J Exec Says Continue to Monitor What the Future Year's Impact Could Be From Tariffs on Our Business

THOMSON REUTERS

FDA: Discontinuation of Manufacture of Pfizer's Trecator, Tablet, 250 Mg - Website

THOMSON REUTERS

NanoViricides Inc. Announces Phase II Clinical Trial for NV-387 to Combat MPox Epidemic

Abbott : Mizuho Raises Target Price to $140 From $130

THOMSON REUTERS

Astrazeneca's Anselamimab Misses Primary Goal in Phase III Amyloidosis Trial, Shares Down

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1379.0648,"timestamp":1752868799999,"preClose":1374.4666,"halted":0,"volume":95962727,"delay":0,"changeRate":0.003345,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.598267,"latestTime":"07-18 16:00:00 EDT","open":1378.9058,"high":1392.0709,"low":1377.9001,"amount":6205677126.969449,"amplitude":0.01031,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.647019,"peRate":21.146563,"turnoverRate":0.006269,"increases":9,"decrements":9,"flats":1,"marketCap":1137445199268.5,"floatMarketCap":1116746960372.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1392.0709,"amplitude":0.01031,"preClose":1374.4666,"low":1377.9001,"pbRate":"3.647019","latestPrice":1379.0648,"volume":95962727,"delay":0,"open":1378.9058,"prevYearClose":1274.8187,"prevWeekClose":1397.679,"prevMonthClose":1377.5769,"prevQuarterClose":1377.5769,"fiveDayClose":1397.679,"twentyDayClose":1359.4229,"sixtyDayClose":1350.4775,"secType":"PLATE","market":"US","turnoverRate":0.006269,"peRate":21.146563,"marketCap":1137445199268.5,"floatMarketCap":1116746960372.5,"timestamp":1752868799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":9,"down":9,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552730483","title":"J&J : Leerink Partners Raises Target Price  to $171 From $153","url":"https://stock-news.laohu8.com/highlight/detail?id=2552730483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552730483?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:48","pubTimestamp":1752749331,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","LU0985320562.USD","LU1066051225.USD","IE0009355771.USD","LU0098860793.USD","LU0889566641.SGD","LU2468319806.SGD","LU1935042991.SGD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU1280957306.USD","LU0320765646.SGD","LU2112291526.USD","LU2089984988.USD","LU1261432733.SGD","IE00B3T34201.USD","IE00BVYPNV92.GBP","LU0912757837.SGD","LU2129689605.HKD","LU0114720955.EUR","LU1059921491.USD","LU1162221912.USD","IE0034235303.USD","LU2430703095.HKD","BK4534","LU1023059063.AUD","LU1267930813.SGD","LU0234572021.USD","LU1430594728.SGD","LU1066051811.HKD","LU1674673691.USD","BK4592","LU1732800096.USD","LU2133065610.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0203345920.USD","LU0345770993.USD","BK4568","IE00BBT3K403.USD","LU1221951046.USD","SG9999001440.SGD","IE00B19Z3B42.SGD","JNJ","LU0234570918.USD","LU1244550221.USD","LU0345769631.USD","LU0640476718.USD","IE0002270589.USD","LU1244550577.SGD"],"gpt_icon":0},{"id":"2552835474","title":"Ocugen to Host Conference Call on Friday, August 1 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2552835474","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552835474?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:30","pubTimestamp":1752748200,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., July  17, 2025  (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117070/0/en/Ocugen-to-Host-Conference-Call-on-Friday-August-1-at-8-30-A-M-ET-to-Discuss-Business-Updates-and-Second-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HST","OCGN","BK4561","BK4581","BK4144","BK4218","BK4588","BK4568","ET","BK4139","BK4585","BK4590","BK4563","BK4181"],"gpt_icon":0},{"id":"2552889434","title":"J&J : Bofa Global Research Raises Price Objective to $175 From $161","url":"https://stock-news.laohu8.com/highlight/detail?id=2552889434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552889434?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:10","pubTimestamp":1752747044,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE0LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU1894683348.USD","SG9999002232.USD","LU0466842654.USD","LU1778281490.HKD","LU2430703178.SGD","LU0320765646.SGD","IE00B2B36J28.USD","LU1929549753.HKD","JNJ","LU0234570918.USD","IE0002270589.USD","LU1057294990.SGD","LU1066051498.USD","IE00B7SZLL34.SGD","LU0058720904.USD","LU0122379950.USD","LU1162221912.USD","SG9999001440.SGD","LU0203345920.USD","LU1280957306.USD","IE000M9KFDE8.USD","IE00BVYPNV92.GBP","IE0034235303.USD","BK4581","LU0114720955.EUR","LU2129689605.HKD","LU0795875169.SGD","IE00B19Z3B42.SGD","LU1267930813.SGD","IE00BN8TJ469.HKD","IE00B3PB1722.GBP","LU1244550494.USD","LU1066053197.SGD","LU1244550221.USD","IE00BLSP4239.USD","BK4550","IE00B3T34201.USD","LU1430594728.SGD","LU1221951129.SGD","LU0795875086.SGD","IE00BBT3K403.USD","LU1261432733.SGD","IE00BFXG1179.USD","LU1023059063.AUD","LU2129689431.USD","LU1061106388.HKD","LU1732799900.SGD","BK4568","LU2468319806.SGD"],"gpt_icon":0},{"id":"2552488827","title":"IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2552488827","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552488827?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:00","pubTimestamp":1752746400,"startTime":"0","endTime":"0","summary":"International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing's promise in medicine.While Moderna isn't looking to replace classical computing with quantum entirely, the company is interested in building a \"quantum-enabled biotechnology pipeline.\" In conjunction with IBM, the pharmaceutical giant sought to explore how algorithms could help create mRNA-based medicines.If that terminology rings a bell, it's because that same mRNA approach is central to Moderna's Covid-19 vaccine. Messenger RNA, as it's known in full, is a molecule that contains instructions that direct cells to make a protein.But there's a catch. An astronomically large number of mRNA sequences could encode any given protein, which makes it difficult to develop treatments.Researchers used Conditional Value at Risk, a risk-assessment technique borrowed from finance, to improve the performance of VQAs. The partners ultimately achieved a record in the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4612","LU1778281490.HKD","BK4543","LU1674673691.USD","MRNA","BK4134","IBM","BK4551","BK4534","BK4585","BK4588","LU1585245621.USD","LU1430594728.SGD","TISI","BK4579","LU1674673428.USD","BK4548","LU1880398471.USD","LU1880398554.USD","BK4575","BK4120","BK4532","BK4538","BK4602","LU0868494617.USD","LU0321505868.SGD","BK4139","BK4501","LU1883839398.USD","BK4568","LU0321505439.SGD"],"gpt_icon":0},{"id":"2552104213","title":"Barclays Remains a Hold on Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2552104213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552104213?lang=en_us&edition=fundamental","pubTime":"2025-07-17 16:37","pubTimestamp":1752741440,"startTime":"0","endTime":"0","summary":"In a report released today, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson, with a price target of $176.00. The company’s ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-hold-on-johnson-johnson-jnj-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-hold-on-johnson-johnson-jnj-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3PB1722.GBP","LU1244550577.SGD","LU0098860793.USD","LU0985320562.USD","BK4585","LU0912757837.SGD","LU0345770308.USD","LU0792757196.USD","IE0002141913.USD","LU2112291526.USD","LU2592432038.USD","IE00BFXG1179.USD","LU1718418525.SGD","LU1244550494.USD","BK4534","LU1732800096.USD","LU1066051225.USD","BK4007","LU1674673691.USD","LU1929549753.HKD","IE00BLSP4239.USD","LU1674673428.USD","IE00B19Z3B42.SGD","LU1074936037.SGD","LU0466842654.USD","LU0345769128.USD","LU1267930813.SGD","IE00B3T34201.USD","JNJ","BK4568","LU1066051811.HKD","LU1894683348.USD","BK4550","BK4588","LU2129689605.HKD","LU0114720955.EUR","LU2133065610.SGD","LU2468319806.SGD","LU0203347892.USD","LU2430703251.USD","LU0345770993.USD","LU2505996509.AUD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU1914381329.SGD","LU1059921491.USD","BK4504","BK4592","LU0058720904.USD"],"gpt_icon":0},{"id":"2552638102","title":"Is Johnson & Johnson a Good Dividend Stock to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2552638102","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552638102?lang=en_us&edition=fundamental","pubTime":"2025-07-17 16:37","pubTimestamp":1752741420,"startTime":"0","endTime":"0","summary":"Johnson & Johnson reported second-quarter results on July 16.Sales of pharmaceuticals have been muted due to a loss of market exclusivity for Stelara.A strong medical technology segment and an expanding pharmaceutical business could keep pushing the dividend higher despite patent expirations.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/17/is-johnson-johnson-a-good-dividend-stock-to-buy-no/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU2505996509.AUD","LU1221951046.USD","LU1023059063.AUD","LU2133065610.SGD","LU0882574055.USD","BK4007","IE00B19Z3581.USD","LU1674673428.USD","LU1929549753.HKD","LU0345770308.USD","BK4592","SG9999002232.USD","LU1674673691.USD","LU0345769631.USD","LU1914381329.SGD","LU1221951129.SGD","LU1244550577.SGD","JNJ","IE00B3PB1722.GBP","SG9999001440.SGD","LU2468319806.SGD","SG9999002224.SGD","LU0792757196.USD","BK4504","LU1066051498.USD","LU0058720904.USD","LU0234570918.USD","IE00BGHQF631.EUR","LU1066051811.HKD","IE00B19Z3B42.SGD","LU1267930813.SGD","LU2112291526.USD","LU1244550221.USD","LU0234572021.USD","LU0345769128.USD","IE000M9KFDE8.USD","LU0345770993.USD","LU0320765646.SGD","IE00BLSP4452.SGD","BK4568","LU0289739699.SGD","LU1718418525.SGD","LU0795875086.SGD","LU1894683348.USD","LU1732800096.USD","IE00B42XCP33.USD","BK4585","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1244550494.USD"],"gpt_icon":0},{"id":"2552177620","title":"Johnson & Johnson: Strong Performance Overshadowed by Biosimilar Competition and Litigation Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2552177620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552177620?lang=en_us&edition=fundamental","pubTime":"2025-07-17 11:15","pubTimestamp":1752722117,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Chris Schott maintained a Hold rating on Johnson & Johnson yesterday and set a price target of $185.00. Chris Schott has given ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/johnson-johnson-strong-performance-overshadowed-by-biosimilar-competition-and-litigation-risks-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/johnson-johnson-strong-performance-overshadowed-by-biosimilar-competition-and-litigation-risks-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2592432038.USD","JNJ","LU2505996509.AUD","BK4127","SG9999001440.SGD","LU0882574055.USD","LU2347655156.SGD","LU1066051498.USD","LU0795875086.SGD","LU1732800096.USD","BK4585","LU0058720904.USD","LU1668664300.SGD","LU1280957306.USD","LU0234570918.USD","LU2271345857.HKD","LU0345769631.USD","LU0158827948.USD","BK4592","LU0225283273.USD","LU1057294990.SGD","LU0106261372.USD","IE00B7SZLL34.SGD","LU2028103732.USD","IE00B4R5TH58.HKD","IE00B1BXHZ80.USD","LU0158827781.USD","LU0912757837.SGD","LU2112291526.USD","LU0006306889.USD","BK4568","IE00B3PB1722.GBP","LU1061106388.HKD","IE00B3T34201.USD","LU2505996681.GBP","LU1032955483.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","IE00BLSP4452.SGD","LU0320765646.SGD","LU2357305700.SGD","LU0889566641.SGD","IE00BLSP4239.USD","IE00BFXG1179.USD","LU1989772840.SGD","IE0009355771.USD","LU2089284900.SGD","IE00BN8TJ469.HKD","LU1059921491.USD","LU1894683264.USD"],"gpt_icon":0},{"id":"2552173426","title":"Johanna Mercier, Chief Commercial Officer, Reports Disposal of Gilead Sciences Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2552173426","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552173426?lang=en_us&edition=fundamental","pubTime":"2025-07-17 05:45","pubTimestamp":1752702333,"startTime":"0","endTime":"0","summary":"Johanna Mercier, the Chief Commercial Officer of Gilead Sciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nNDL6ppDlx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1585245621.USD","LU2468319806.SGD","BK4550","LU2324357040.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","IE0002270589.USD","IE00B19Z3581.USD","LU0823416689.USD","SG9999015986.USD","BK4566","BK4583","IE00B7SZLL34.SGD","LU1674673428.USD","SG9999015945.SGD","LU1430594728.SGD","LU0234570918.USD","LU2087621335.USD","IE00B3T34201.USD","LU0320765992.SGD","BK4585","LU0289739699.SGD","LU0889565916.HKD","SG9999015978.USD","GILD","LU1571399168.USD","BK4578","BK4532","LU1674673691.USD","LU1066053197.SGD","IE00BSNM7G36.USD","LU1066051498.USD","BK4139","BK4568","BK4588","LU0058720904.USD","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU0109394709.USD","LU1839511570.USD"],"gpt_icon":0},{"id":"2552731021","title":"Gilead Sciences CFO Andrew D. Dickinson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2552731021","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552731021?lang=en_us&edition=fundamental","pubTime":"2025-07-17 05:42","pubTimestamp":1752702121,"startTime":"0","endTime":"0","summary":"Andrew D. Dickinson, the Chief Financial Officer of Gilead Sciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nNDL5gjqQB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1674673691.USD","SG9999015952.SGD","LU1066051498.USD","BK4532","SG9999015986.USD","IE00BZ1G4Q59.USD","BK4550","LU1674673428.USD","LU1430594728.SGD","LU1571399168.USD","BK4585","IE00B3T34201.USD","LU0889565916.HKD","LU1778281490.HKD","LU1839511570.USD","LU2324357040.USD","BK4566","LU2468319806.SGD","LU1066053197.SGD","SG9999015978.USD","IE00BSNM7G36.USD","LU0289739699.SGD","LU2087621335.USD","IE00B7SZLL34.SGD","BK4578","LU2089984988.USD","LU0109394709.USD","LU0823416689.USD","LU1585245621.USD","SG9999015945.SGD","BK4568","IE0002270589.USD","BK4588","IE00B19Z3581.USD","LU0234570918.USD","LU0320765992.SGD","GILD","LU0058720904.USD"],"gpt_icon":0},{"id":"2552178470","title":"Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2552178470","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552178470?lang=en_us&edition=fundamental","pubTime":"2025-07-17 04:15","pubTimestamp":1752696900,"startTime":"0","endTime":"0","summary":"NEW YORK, July  16, 2025  (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2025 financial results on Wednesday, August 6, 2025 before the U.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/16/3116843/0/en/Royalty-Pharma-to-Announce-Second-Quarter-2025-Financial-Results-on-August-6-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0456855351.SGD","LU0868494617.USD","BK4581","LU1894683348.USD","LU0321505868.SGD","LU0225284248.USD","BK4550","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0122379950.USD","LU1894683264.USD","LU1066051498.USD","LU0058720904.USD","PFE","IE00BLSP4239.USD","BK4007","LU0306806265.USD","LU0289739699.SGD","SG9999001176.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","LU1066053197.SGD","BK4588","LU1023059063.AUD","BK4585","LU0170899867.USD","SG9999002224.SGD","LU0306807586.USD","LU0321505439.SGD","SG9999002232.USD","SG9999003800.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4534","BK4533","BK4592","BK4568","BK4599","SG9999011175.SGD","SG9999013999.USD","LU0234572021.USD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2552817882","title":"US STOCKS-Wall Street ends higher after brief slump on Powell firing confusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2552817882","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552817882?lang=en_us&edition=fundamental","pubTime":"2025-07-17 04:00","pubTimestamp":1752696059,"startTime":"0","endTime":"0","summary":"US STOCKS-Wall Street ends higher after brief slump on Powell firing confusionMarkets recover after brief selloff on Powell firing reportsBank stocks mixed after Q2 earningsU.S June PPI unchanged on a monthly basisUpdates to the close, adds analyst commentBy David French. It was the fifth session in six that the technology-heavy Nasdaq index has posted a record close.Since Trump's April tariff announcement, which initially sent U.S. equities into a spin, U.S. stock markets have been on a tear. The S&P 500 most recently posted a record finish last week.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nL1N3TD0YK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU1989764664.SGD","IE0034235188.USD","NVIW.SI","LU2430703095.HKD","NVDU","LU2456880835.USD","NVD3.UK","BK4568","IE00BMPRXQ63.HKD","LU1037948541.HKD","BAC","IE00BFXG1179.USD","LU2065170008.USD","3NVD.UK","SG9999014575.USD","LU2468319806.SGD","LU1934455863.HKD","LU0444971666.USD","LU2294711713.HKD","IE00BQXX3C00.GBP","2NVD.UK","BK4127","LU1894683348.USD","LU0965508806.USD","LU1868836591.USD","LU2237443465.HKD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0127658192.USD","LU1668664300.SGD","LU1718418525.SGD","LU2357125470.USD","SNVD.UK","NVDS.UK","NVDS","NVDY","IE00B3PB1722.GBP","IE00BMPRXN33.USD","NVD2.UK","LU2236285917.USD","NVD","LU2360107168.USD","LU2491050071.SGD","NVDD","NVDX","BK4141","LU0466842654.USD"],"gpt_icon":1},{"id":"2552122949","title":"J&J Sees Lower Tariff Risk for the Year -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2552122949","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552122949?lang=en_us&edition=fundamental","pubTime":"2025-07-17 00:34","pubTimestamp":1752683640,"startTime":"0","endTime":"0","summary":"1234 ET - J&J now expects about $200 million in added costs from tariffs this year, cutting in half the $400 million it forecast in April. The updated outlook is exclusively related to lower tariff rates on medical technology products, the company says during a call with analysts. J&J will look to reinvest the differential to accelerate its pipeline, it says. Still, CEO Joaquin Duato reiterates that effective tax legislation, including recently passed policies, is the key to creating American manufacturing jobs. He previously says the most effective way to build domestic manufacturing capacity is tax policy, not tariffs. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","JNJ","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU1585245621.USD","LU1244550221.USD","LU2505996509.AUD","LU0889566641.SGD","IE00B42XCP33.USD","IE00BJT1NW94.SGD","BK4504","LU1267930813.SGD","IE00B7SZLL34.SGD","LU1674673428.USD","LU1430594728.SGD","IE00BLSP4239.USD","SG9999002232.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0234570918.USD","LU0234572021.USD","BK4559","IE0034235303.USD","LU1162221912.USD","LU1506573853.SGD","IE00B3T34201.USD","LU0203347892.USD","LU0985320562.USD","LU1023059063.AUD","LU0320765646.SGD","LU0795875086.SGD","LU1066051811.HKD","LU1074936037.SGD","BK4534","LU2430703251.USD","LU0098860793.USD","LU1261432733.SGD","BK4007","LU2602419157.SGD","LU1066051225.USD","LU1066053197.SGD","LU0640476718.USD","LU1718418525.SGD","BK4568","LU0912757837.SGD","IE00BLSP4452.SGD","LU0345770308.USD","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"2552124965","title":"Pfizer’s Latest Clinical Study: A New Hope for Advanced Melanoma Treatment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2552124965","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552124965?lang=en_us&edition=fundamental","pubTime":"2025-07-17 00:15","pubTimestamp":1752682536,"startTime":"0","endTime":"0","summary":"Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 2 clinical study titled A Study Comparin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-latest-clinical-study-a-new-hope-for-advanced-melanoma-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-latest-clinical-study-a-new-hope-for-advanced-melanoma-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505868.SGD","SG9999013999.USD","LU0225284248.USD","PFE","AEIS","LU0306806265.USD","LU0985481810.HKD","BK4211","HOPE","LU1894683348.USD","IE00B19Z3581.USD","IE00B19Z4B17.USD","LU0170899867.USD","LU0321505439.SGD","SG9999003800.SGD","SG9999002232.USD","LU0306807586.USD","BK4007","SGXZ57979304.SGD","LU0456855351.SGD","BK4585","SG9999011175.SGD","SG9999001176.USD","BK4592","LU0225771236.USD","BK4534","LU0058720904.USD","LU1057294990.SGD","IE0002270589.USD","IE000M9KFDE8.USD","LU0122379950.USD","SG9999001176.SGD","LU1066051498.USD","BK4599","BK4568","LU1023059063.AUD","LU0868494617.USD","LU1894683264.USD","IE00BLSP4239.USD","LU0289739699.SGD","IE00BBT3K403.USD","IE00B66KJ199.SGD","LU1883839398.USD","BK4588","LU1066053197.SGD","BK4550","BK4533","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4581"],"gpt_icon":0},{"id":"2552124987","title":"Gilead Sciences Advances in Triple-Negative Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2552124987","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552124987?lang=en_us&edition=fundamental","pubTime":"2025-07-17 00:13","pubTimestamp":1752682421,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)), Gilead Sciences (($CC:GILD.CUR)) announced an update on their ongoing clinical study. Gilead Sciences is conducting a st...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-in-triple-negative-breast-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-in-triple-negative-breast-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0234570918.USD","BK4566","LU1778281490.HKD","LU0823416689.USD","LU1674673691.USD","LU2087621335.USD","SG9999015978.USD","LU2089984988.USD","BK4585","IE00BKVL7J92.USD","LU0320765992.SGD","BK4588","LU1585245621.USD","BK4550","LU1430594728.SGD","LU1066051498.USD","SG9999015986.USD","GILD","LU1674673428.USD","SG9999015945.SGD","IE0002270589.USD","LU0889565916.HKD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","BK4578","IE00B3T34201.USD","BK4532","LU1839511570.USD","LU1066053197.SGD","LU1571399168.USD","LU2468319806.SGD","BK4139","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","LU0058720904.USD","IE00BSNM7G36.USD","LU2324357040.USD","BK4568","LU0289739699.SGD","BK4583"],"gpt_icon":0},{"id":"2552212174","title":"Pfizer’s BeneFIX Study Completion: Market Implications and Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=2552212174","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552212174?lang=en_us&edition=fundamental","pubTime":"2025-07-17 00:01","pubTimestamp":1752681672,"startTime":"0","endTime":"0","summary":"Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. recently completed a clinical study titled ‘BeneFIX Drug Use R...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-benefix-study-completion-market-implications-and-insights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-benefix-study-completion-market-implications-and-insights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0868494617.USD","LU0225771236.USD","LU1894683348.USD","BK4568","IE00BBT3K403.USD","LU1066053197.SGD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU0289739699.SGD","SG9999003800.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU0306807586.USD","BK4533","IE0002270589.USD","SG9999013999.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4550","LU0122379950.USD","LU0456855351.SGD","BK4007","IE00B19Z3581.USD","PFE","SG9999002232.USD","LU0321505439.SGD","BK4581","BK4599","LU1023059063.AUD","LU1883839398.USD","LU1057294990.SGD","SG9999001176.SGD","BK4534","BK4588","LU0321505868.SGD","IE00BLSP4239.USD","SG9999001176.USD","SG9999002224.SGD","LU0234572021.USD","LU1066051498.USD","BK4585","BK4592","LU0225284248.USD","LU0058720904.USD","LU1894683264.USD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2551312348","title":"J&J Exec Says Continue to Monitor What the Future Year's Impact Could Be From Tariffs on Our Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2551312348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551312348?lang=en_us&edition=fundamental","pubTime":"2025-07-16 21:06","pubTimestamp":1752671170,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TD0HI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1732799900.SGD","JNJ","LU2347655156.SGD","LU1280957306.USD","LU2112291526.USD","IE00BGHQF631.EUR","IE00B3T34201.USD","LU2602419157.SGD","IE00BBT3K403.USD","LU0234572021.USD","IE00BDGV0183.EUR","LU0466842654.USD","BK4568","LU1778281490.HKD","LU0345770308.USD","BK4504","IE00BVYPNW00.USD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","IE0002141913.USD","LU1718418525.SGD","LU1032466523.USD","BK4532","LU1221951046.USD","IE00BFXG1179.USD","LU1066051811.HKD","LU1914381329.SGD","LU0795875169.SGD","LU0122379950.USD","LU0114720955.EUR","LU1929549753.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU0985320562.USD","LU2129689431.USD","IE00BN8TJ469.HKD","LU2129689514.USD","LU2430703251.USD","BK4550","LU0320765646.SGD","LU2468319806.SGD","LU1059921491.USD","LU2505996681.GBP","LU1061106388.HKD","LU2129689605.HKD","LU2505996509.AUD","SG9999002224.SGD","IE00B2B36J28.USD","LU1074936037.SGD","LU0882574055.USD"],"gpt_icon":0},{"id":"2551231701","title":"FDA: Discontinuation of Manufacture of Pfizer's Trecator, Tablet, 250 Mg - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2551231701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551231701?lang=en_us&edition=fundamental","pubTime":"2025-07-16 21:02","pubTimestamp":1752670927,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TD137:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066051498.USD","LU1883839398.USD","BK4581","LU0289739699.SGD","LU0306807586.USD","BK4550","LU0321505439.SGD","LU0868494617.USD","BK4599","SG9999011175.SGD","LU0122379950.USD","LU0225771236.USD","SG9999001176.USD","LU0058720904.USD","BK4007","SG9999003800.SGD","LU0456855351.SGD","LU0306806265.USD","PFE","IE00BLSP4452.SGD","LU0170899867.USD","LU0321505868.SGD","SG9999002224.SGD","BK4533","IE000M9KFDE8.USD","LU1023059063.AUD","SG9999001176.SGD","BK4568","LU1066053197.SGD","BK4534","IE00BLSP4239.USD","SG9999013999.USD","BK4585","LU1894683348.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4588","BK4592","IE00BBT3K403.USD","IE00B19Z3581.USD","LU0225284248.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU1057294990.SGD","IE0002270589.USD","SG9999002232.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2551284411","title":"NanoViricides Inc. Announces Phase II Clinical Trial for NV-387 to Combat MPox Epidemic","url":"https://stock-news.laohu8.com/highlight/detail?id=2551284411","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551284411?lang=en_us&edition=fundamental","pubTime":"2025-07-16 20:33","pubTimestamp":1752669220,"startTime":"0","endTime":"0","summary":"NanoViricides, Inc., a clinical-stage company specializing in broad-spectrum antiviral therapies, has announced the development of a clinical trial protocol for a Phase II study of NV-387, aimed at treating MPox disease in the African region. This randomized clinical trial will compare NV-387 treatment with the standard of care to evaluate the dosing regimen's safety, tolerability, and effectiveness against the MPXV virus. The trial comes in response to the ongoing MPox epidemic and the extension of the Public Health Emergency of International Concern  by the World Health Organization. No results from this impending study have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nNDL50npL3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2551142799","title":"Abbott : Mizuho Raises Target Price to $140 From $130","url":"https://stock-news.laohu8.com/highlight/detail?id=2551142799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551142799?lang=en_us&edition=fundamental","pubTime":"2025-07-16 18:54","pubTimestamp":1752663290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TD050:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","LU2133065610.SGD","BK4581","LU2237957902.USD","LU2237957811.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","ABT","LU2112291526.USD","BK4504","LU1914381329.SGD","LU1989763427.SGD","BK4566","BK4082","LU1691799644.USD","LU2089984988.USD","SGXZ23171101.USD","LU0266013472.USD","SG9999004303.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00B2B36J28.USD","BK4588","LU1721429741.USD","LU1023059063.AUD","IE0009355771.USD","BK4585","LU0170899867.USD","SG9999002224.SGD","SG9999002232.USD","LU1989763690.USD","LU1721429402.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","BK4533","BK4592","BK4568","IE0002141913.USD","LU1061106388.HKD","LU0234572021.USD"],"gpt_icon":0},{"id":"2551142370","title":"Astrazeneca's Anselamimab Misses Primary Goal in Phase III Amyloidosis Trial, Shares Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2551142370","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551142370?lang=en_us&edition=fundamental","pubTime":"2025-07-16 18:30","pubTimestamp":1752661854,"startTime":"0","endTime":"0","summary":"Astrazeneca (AZN) said Wednesday its phase III trial for experimental therapy, anselamimab, in patients with advanced light chain amyloidosis did not meet its primary endpoint compared to placebo.The ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","III","LU2456880835.USD","BK4585","LU0889565916.HKD","LU0109394709.USD","LU1829250122.USD","BK4588","BK4007","AZN","LU2236285917.USD","LU2417539215.USD","LU2462157665.USD","LU0320765992.SGD","BK4134"],"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":4,"totalSize":237,"code":"91000000","status":"200"}]}}